Here below are the publications (2) participated by Federica Sallusto along with Claudio Gobbi (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Persistent longitudinal T cell responses after SARS-CoV-2 mRNA vaccines in MS patients on different disease modifying treatments
Multiple Sclerosis and Related Disorders, 6 agosto 2024

2) Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
Neurology Neuroimmunology & Neuroinflammation, 17 novembre 2022
Federica Sallusto
is currently collaborating with
Istituto di Ricerca in Biomedicina (IRB) (Rif. IRB)
Via Francesco Chiesa 5
6500 Bellinzona
Federica Sallusto
on behalf of
Istituto di Ricerca in Biomedicina (IRB) USI (Rif. IRB)
is currently participating in the Research Group
Immunologia Cellulare
as Group Leader [Rif. 55110]